In the last trading session, 4.23 million shares of the VolitionRX Ltd (AMEX:VNRX) were traded, and its beta was 1.19. Most recently the company’s share price was $0.58, and it changed around -$0.01 or -1.37% from the last close, which brings the market valuation of the company to $53.92M. VNRX currently trades at a discount to its 52-week high of $1.23, offering almost -112.07% off that amount. The share price’s 52-week low was $0.43, which indicates that the current value has risen by an impressive 25.86% since then. We note from VolitionRX Ltd’s average daily trading volume that its 10-day average is 0.24 million shares, with the 3-month average coming to 141.79K.
VolitionRX Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended VNRX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. VolitionRX Ltd is expected to report earnings per share of -0.06 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
VolitionRX Ltd (AMEX:VNRX) trade information
Instantly VNRX has showed a red trend with a performance of -1.37% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6496 on recent trading dayincreased the stock’s daily price by 10.71%. The company’s shares are currently down -18.84% year-to-date, but still down -1.66% over the last five days. On the other hand, VolitionRX Ltd (AMEX:VNRX) is -16.12% down in the 30-day period. We can see from the shorts that 0.44 million shares have been sold at a short interest cover period of 3.71 day(s).
VolitionRX Ltd (VNRX) estimates and forecasts
VolitionRX Ltd share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -21.36 percent over the past six months and at a 44.00% annual growth rate that is well above the industry average of 17.10%. The year-over-year growth rate is expected to be 101.20%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 545.34k in revenue for the current quarter. 1 analysts expect VolitionRX Ltd to make 800k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 243.97k and 171.54k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 123.53%. Forecasts for the next quarter put sales growth at 366.36%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 2.75%.
VNRX Dividends
VolitionRX Ltd’s next quarterly earnings report is expected to be released in January.
VolitionRX Ltd (AMEX:VNRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 22.82% of VolitionRX Ltd shares, and 19.11% of them are in the hands of institutional investors. The stock currently has a share float of 24.76%. VolitionRX Ltd stock is held by 23.0 institutions, with LAGODA INVESTMENT MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 6.6352% of the shares, which is about 5.44 million shares worth $3.29 million.
VANGUARD GROUP INC, with 0.7768% or 0.64 million shares worth $0.39 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
